Over the past decade, the landscape of processes that pharmaceutical and biotech companies are outsourcing has evolved dramatically. Due to increasing pressure to reduce costs and improve efficiencies many Life Sciences companies, regardless of size, have shifted from a largely in-house model to one that relies upon external outsourced service providers. In general, companies outsource for one or more of three reasons: cost, capacity or capability. 

This whitepaper explores where there are outsourcing opportunities in the labeling process and key considerations to help ensure that favorable outcomes are achieved.